IMREVITE Trademark

Trademark Overview

On Monday, August 15, 2016, a trademark application was filed for IMREVITE with the United States Patent and Trademark Office. The USPTO has given the IMREVITE trademark a serial number of 87138926. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 19, 2020. This trademark is owned by Bristol-Myers Squibb Company. The IMREVITE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
imrevite

General Information

Serial Number87138926
Word MarkIMREVITE
Filing DateMonday, August 15, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 19, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 18, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 18, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, October 19, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 19, 2020ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 17, 2020EXTENSION 5 GRANTED
Thursday, March 5, 2020EXTENSION 5 FILED
Tuesday, March 17, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 5, 2020TEAS EXTENSION RECEIVED
Saturday, August 24, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 22, 2019EXTENSION 4 GRANTED
Thursday, August 22, 2019EXTENSION 4 FILED
Thursday, August 22, 2019TEAS EXTENSION RECEIVED
Wednesday, March 13, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 11, 2019EXTENSION 3 GRANTED
Monday, March 11, 2019EXTENSION 3 FILED
Monday, March 11, 2019TEAS EXTENSION RECEIVED
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, September 14, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 12, 2018EXTENSION 2 GRANTED
Wednesday, September 12, 2018EXTENSION 2 FILED
Wednesday, September 12, 2018TEAS EXTENSION RECEIVED
Tuesday, August 21, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 21, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, July 9, 2018ASSIGNED TO EXAMINER
Saturday, March 10, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 8, 2018EXTENSION 1 GRANTED
Thursday, March 8, 2018EXTENSION 1 FILED
Thursday, March 8, 2018TEAS EXTENSION RECEIVED
Tuesday, September 12, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 18, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 18, 2017PUBLISHED FOR OPPOSITION
Wednesday, June 28, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 5, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, June 3, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 1, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 1, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 1, 2016NOTIFICATION OF PRIORITY ACTION E-MAILED
Thursday, December 1, 2016PRIORITY ACTION E-MAILED
Thursday, December 1, 2016PRIORITY ACTION WRITTEN
Sunday, November 27, 2016ASSIGNED TO EXAMINER
Thursday, August 18, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 18, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

imrevite diseases pharmaceutical human anti preparations disorders organ solid auto immune